Similar Articles
Macrophage Activation Syndrome: A Potentially Fatal Complication of Kawasaki Disease
Kallol BOSE, Sudip SAHA, Prabir SAHA, Piyasi MONDAL
DOI: 10.5606/ArchRheumatol.2015.5186
Issue: Volume 30 - Issue 2 - June 2015
7522
4970
Reliability and Validity of the Turkish Adaptation of VITACORA-19 in Patients with Psoriatic Arthritis
Berna TANDER, Yasemin ULUS, Yüksel TERZİ, Yeliz ZAHİROĞLU, Hakan KESMEN, Bayram FARİSOĞULLARI, Yeşim AKYOL, Ayhan BİLGİCİ, Ömer KURU
DOI: 10.5606/ArchRheumatol.2016.5741
Issue: Volume 31 - Issue 4 - December 2016
7402
5321
Factors associated with self-reported capacity to walk, jog and run in individuals with systemic lupus erythematosus
Gizem İrem KINIKLI, Susanne PETTERSSON, Sevilay KARAHAN, Iva GUNNARSSON, Elisabet SVENUNGSSON, Carina BOSTRÖM
DOI: 10.46497/ArchRheumatol.2021.8193
Issue: Volume 36 - Issue 1 - March 2021
1755
2172
Is COVID-19 multisystem inflammatory syndrome a new variant of Kawasaki Disease?
Khawla Abu Hammour, Rana Abu Farha, Qusai Manaseer, Tasnim Dawoud, Walid Abu Hammour
DOI: 10.46497/ArchRheumatol.2022.9086
Issue: Volume 37 - Issue 2 - June 2022
1910
2368
The relationship between Mycoplasma and Kawasaki disease in pediatric patients: An updated systematic review and meta-analysis
Min Cheng, Gaihuan Zheng, Lu Gao, Bihong Zhang
DOI: 10.46497/ArchRheumatol.2023.10149
Issue: Volume 39 - Issue 1 - March 2024
1010
2085